Answers are grounded in this paper and cite their sources.
) as exogenous stimuli that can provide on-demand remote controllability for customized deep tumor therapy with a low inter-patient variation. Strikingly, the utilization of dual endogenous and/or exogenous stimuli provides a new direction for efficient cancer therapy. This review highlights recent advances in the utilization of various endogenous and exogenous stimuli to activate the reactions of nanocarriers for ferroptosis-based cancer therapy that can inspire the field of cancer therapy, particularly for the treatment of intractable tumors.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: